Antenatal Breastmilk Expression in Pregnant Women at High Risk of Preterm Birth

In this randomized controlled study, the investigators aim to examine if antenatal breastmilk expression (aBME) from week 28 in high-risk pregnancies is a safe and effective method to ensure early access to mother's own milk. In addition, this study will analyze and compare colostrum from pregnancy with colostrum after birth, investigates women's confidence in breastfeeding and breastfeeding establishment as well as measures oxytocin levels during aBME and active labour with no aBME.

NCT Number	NCT07191366
Lead Sponsor	Odense University Hospital Collaborators: Aabenraa Hospital, Esbjerg Hospital - University Hospital of Southern Denmark, Kolding Sygehus, University of Aarhus
Conditions	Preterm Birth, PPROM, Preeclampsia, Previous Preterm Birth
Enrollment	250 participants
Start Date	2026-09
Primary Completion	2029-01 (estimated)
Study Completion	2029-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-24